Laura Banaszkiewicz
Publikacje
Filtry
wszystkich: 11
Katalog Publikacji
Rok 2023
-
Determination of benzodiazepines and Z-hypnotic drugs in whole blood samples by GC–MS/MS: Method development, validation and application
PublikacjaBenzodiazepines (BZDs) and Z-drugs are widely used as anxiolytics, sedative hypnotics, anticonvulsants and muscle relaxants. “Designer benzodiazepines” (DBZDs) are a new psychoactive substance class consisting of benzodiazepine derivatives that are not allowed for medical use and are known for being used recreationally. From a toxicologist standpoint, the huge number of such substances implicate a necessity for developing fast...
Rok 2022
-
Long-Term Stability of Benzodiazepines and Z-Hypnotic Drugs in Blood Samples Stored at Varying Temperatures
PublikacjaBenzodiazepines (BZDs) and Z-drugs are among the most commonly prescribed pharmaceuticals in the world and are considered standard care for various mental illnesses and for treatment of sleeping and anxiety disorders, alcohol withdrawal, muscle spasms and epilepsy. Some BZDs are not allowed as pharmaceuticals in many countries, and they are used as "designer benzodiazepines" (DBZDs). All these compounds are typically screened in...
Rok 2021
-
Development and validation of a method for the simultaneous analysis of fatty acid ethyl esters, ethyl sulfate and ethyl glucuronide in neonatal meconium: application in two cases of alcohol consumption during pregnancy
PublikacjaAlcohol consumption during pregnancy constitutes one of the leading preventable causes of birth defects and neurodevelopmental disorders in the exposed children. Fatty acid ethyl esters (FAEEs), ethyl glucuronide (EtG) and ethyl sulfate (EtS) have been studied as potential biomarkers of alcohol consumption. However, most analytical approaches proposed for their analysis in meconium samples consist of separated extraction procedures...
-
Fatal N-Ethylhexedrone Intoxication
PublikacjaN-Ethylhexedrone [2-(ethyloamino)-1-phenylhexan-1-one; α-ethylaminohexanophenone; NEH] is one of the most recent synthetic cathinones that appeared on the illegal market in late 2015. The majority of information concerning the model of consumption of NEH and its impact on the body originates only from self-reports from grey literature websites and drug forums. There are only limited data associated with the concentrations of NEH...
Rok 2020
-
Development and validation of a GC–MS/MS method for the determination of 11 amphetamines and 34 synthetic cathinones in whole blood
PublikacjaPurpose Psychoactive compounds that contain a phenylethylamine structure (such as amphetamine-type stimulants and synthetic cathinones) are one of the major classes of stimulants on the recreational drug market. Approximately 670 new psychoactive substances (NPS) are monitored only in Europe; however, new psychoactive compounds are being developed for illicit trade each year. In this context, the development of new analytical procedures...
-
Rapid and simple multi-analyte LC–MS/MS method for the determination of benzodiazepines and Z-hypnotic drugs in blood samples: Development, validation and application based on three years of toxicological analyses
PublikacjaBenzodiazepines (BZDs) and Z-drugs have been particularly important treatments for sleeping and anxiety disorders for many years. However, recently, a number of new benzodiazepines (named designer benzodiazepines, DBZDs) were synthesised, but some of them have never been used in the clinic; they reached the black drug market as new psychoactive substances and are used for recreational purposes. The abuse of these substances has...
Rok 2019
-
Application of GC-MS/MS technique for the determination of benzodiazepines in blood samples
PublikacjaAbstract Benzodiazepines (BZD) are widely used as pharmaceuticals in medicine. However, due to psychostimulatory effect of BZD, in the last decade, they are more and more often used as drugs of abuse. These compounds produce similar effects to classical illicit drugs and are sold as “legal” alternatives to them as new psychoactive substances (NPS). Currently new BZD, named designer benzodiazepines (DBZD), are synthesized each year...
-
Nowe substancje psychoaktywne - nowe wyzwania analityczne
PublikacjaNowe substancje psychoaktywne stanowią poważny problem ekonomiczno-społeczny i zdrowotny ze względu na swoje właściwości psychoaktywne oraz uzależniające. Niejednokrotnie zdarza się, że właściwości fizykochemiczne oraz wpływ na organizm człowieka związków z grupy NPS nie są zbadane zanim trafią do nielegalnego obrotu. Wśród substancji należących do NPS wyróżnia się takie grupy chemiczne jak: syntetyczne kannabinoidy, katynony,...
-
Quantification of unconjugated and total ibuprofen and its metabolites in equine urine samples by gas chromatography–tandem mass spectrometry: Application to the excretion study
PublikacjaIbuprofen (IBU) is a widely used nonsteroidal anti-inflammatory drug (NSAID) in human and also veterinary medicine. NSAIDs are usually highly metabolized compounds in horses; they are often present in equine urine, mostly in their conjugated forms (glucuronides). Thus, hydrolysis to cleave the glucuronide linkage prior to anti-doping analysis is often necessary for improving detection. In this study, unconjugated and total IBU...
-
Syntetyczne opioidy – najsilniejsze narkotyki. Część II. Metody wykrywania i oznaczania w różnych materiałach biologicznych
PublikacjaDo naturalnych opioidów zalicza się opiaty, które występują w maku i jego przetworach, tj. morfina i kodeina, z których, po odpowiedniej modyfikacji chemicznej, otrzymuje się półsyntetyczne opiaty (np. heroinę i oksykodon). Do syntetycznych opioidów zaliczają się głównie silne leki przeciwbólowe, w tym: fentanyl, tramadol, metadom i buprenorfina. Używanie tych związków bez odpowiedniej opieki medycznej może prowadzić do zagrożenia...
-
Syntetyczne opioidy - najsilniejsze narkotyki. Cz.I. Rozpowszechnienie, stosowanie i charakterystyka
PublikacjaFentanyl stanowi silny syntetyczny środek przeciwbólowy z grupy opioidów o krótkim czasie działania, wskazanym jako lek u pacjentów paliatywnych i nowotworowych. Jest dostępny w formie plastrów transdermalnych, płynu, czy tabletek. Fentanyl wykazuje dużą pozorną obojętność dystrybucji, krótki okres półtrwania w osoczu i szeroką biotransformację. Wykorzystywany jako substancja odurzająca ze względu na silne właściwości uzależniające...
wyświetlono 1350 razy